Investigator(s): The Lundquist Institute

LOS ANGELES – (May 2, 2013) – Patients with increasing accumulations of coronary artery calcium were more than six times more likely to suffer from a heart attack or die from heart disease than patients who didn’t have increasing accumulations, according to a recent study published in the Journal of the American College of Cardiology.

Investigator(s): The Lundquist Institute

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) honored two of its legendary physician-researchers Wednesday night and celebrated the 10th anniversary of the federal approval of a life-saving therapy developed at the institute.

Guests at the 10th Annual Legends event at Palos Verdes Golf Club celebrated the lives and legacies of David Heber, MD, PhD, and Ronald J. Nelson, MD, both of whom remembered fondly their early years at Harbor-UCLA Medical Center.

DTB_7692DTB_8417

Investigator(s): Christina Chung-Lun Wang, MD

The American Society for Andrology (ASA) presented its highest honor, The Distinguished Andrologist Award for 2013, to Christina Wang, MD, a Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) lead researcher who specializes in the study of male reproductive health and disease.

The organization dedicated to the study of male reproduction presented the award to Dr. Wang during its annual meeting April 13 in San Antonio, TX.

Investigator(s): The Lundquist Institute

LOS ANGELES – (March 20, 2013) – Post-menopausal women, who often suffer from joint pain, could find some long-term relief by taking estrogen-only medication, according to a new study based on the Women’s Health Initiative (WHI) that was released online today by the journal, Menopause.

Investigator(s): The Lundquist Institute

LOS ANGELES – (March. 13, 2013) – Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that 33 of its physician-researchers rank among America’s Top Doctors and/or among Southern California Super Doctors. The two honors are presented annually, and they are based on recommendations from other physicians and health care professions.

LOS ANGELES – (March. 4, 2013) – Grandmother’s cigarette smoking could be responsible for her grandchild’s asthma, and the recent discovery of this multi-generational transmission of disease suggests the environmental factors experienced today could determine the health of family members for generations to come, two Los Angeles Biomedical Research Institute (LA BioMed) lead researchers write in the March edition of Review of Obstetrics and Gynecology.

Investigator(s): Anita L Nelson, MD

LOS ANGELES (Feb. 14, 2013) – New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.

Investigator(s): Jerome I Rotter, MD

LOS ANGELES (Feb. 14, 2013) – Jerome I. Rotter, MD, a pioneer in the field of medical genetics, is joining the faculty at Los Angeles Biomedical Research Institute (LA BioMed) and bringing a team of experts to found a new institute focused on improving the health of the diverse communities served by LA BioMed and Harbor-UCLA Medical Center, David I. Meyer, PhD, LA BioMed president and CEO, announced today.

Investigator(s): The Lundquist Institute

LOS ANGELES (Jan. 23, 2013) – With the rising awareness of the so-called “superbugs,” bacteria that are resistant to most known antibiotics, three infectious disease experts writing in the Jan. 24 edition of the New England Journal of Medicine called for novel approaches based on a “reconceptualization of the nature of resistance, disease and prevention.”

Investigator(s): The Lundquist Institute

LOS ANGELES (Jan. 16, 2013) – In a promising finding for epileptic patients suffering from persistent seizures known as status epilepticus, researchers reported today that new medication could help halt these devastating seizures. To do so, it would have to work directly to antagonize NMDA receptors, the predominant molecular device for controlling synaptic activity and memory function in the brain.